15 completed, 6 not yet recruiting, 5 recruiting, 5 unknown. 15 Not applicable, 6 Phase 2, 3 Phase 4, 2 Early Phase 1, 1 Phase 1.
Follow Vestibular Migraine: new trials by email Literature Review of Vestibular Migraine trials Research Report on Vestibular Migraine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study Rimegepant, Flunarizine - Vestibular Migraine | Phase 2 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 400 | 2026-12-01 | 2026-08-07 |
| Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) - Vestibular Migraine | Not yet recruiting | Boston Children's Hospital | 70 | 2026-12-01 | 2026-10-22 | |
| Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness Virtual Reality - Persistent Postural Perceptual Dizziness, Vestibular Migraine | Early Phase 1 | Recruiting | Boston Children's Hospital | 12 | 2026-08-03 | 2026-10-22 |
| Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM) Galcanezumab, Erenumab 70 mg, Eptinezumab - Migraine Associated Vertigo, Tinnitus | Phase 4 | Not yet recruiting | Stanford University | 120 | 2026-07-01 | 2026-06-17 |
| Exploring Mild Electrical Vestibular Stimulation as a New Treatment for Dizziness and Migraine Symptoms Electrical Vestibular Stimulation, Electrical Vestibular Stimulation Sham - Vestibular Migraine | Not applicable | Not yet recruiting | University of Calgary | 50 | 2026-02-01 | 2026-01-26 |
| Acute Treatment of Vestibular Migraine by Rimegepant First dose rimegepant, second dose placebo, First dose placebo, second dose rimegepant - Vestibular Migraine | Phase 4 | Recruiting | Wensheng Qu | 80 | 2025-12-01 | 2026-10-13 |
| Chinese Real-world Study of Treatment of Vestibular Migraine CGRP R Inhibitor; CGRP Inhibitor, none-CGRP - Vestibular Migraine, Dizziness | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2000 | 2025-12-01 | 2025-10-02 | |
| The R-E-V-I-V-A-L Study Rimegepant, Placebo - Vestibular Migraine | Phase 2 | Active not recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 240 | 2025-06-01 | 2025-06-25 |
| A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment Rimegepant, Placebo - Vestibular Migraine, Adults 18 Years and Older (no Other Exclusion Criteria) | Phase 2 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 240 | 2025-06-01 | 2025-05-14 |
| Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes a blood withdrawal will be obtained, blood withdrawal - Vertigo, Meniere's Disease | Recruiting | IRCCS San Raffaele | 250 | 2025-04-09 | 2026-04-08 | |
| Virtual Reality-Based Vestibular Rehabilitation in Vestibular Migraine Home-Based Vestibular Rehabilitation, Virtual Reality-Based Vestibular Rehabilitation - Vestibular Migraine | Not applicable | Completed | Ege University | 40 | 2025-03-01 | 2026-03-27 |
| Health Belief Model Scale Development for Disability and Abilities in Vestibular Migraine Patients Vestibular Migraine Education / Awareness Session - Vestibular Migraine | Not applicable | Completed | Istanbul Aydın University | 213 | 2024-12-01 | 2026-03-13 |
| The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines Otolith Device Active, Otolith Device Inactive - Vestibular Migraine | Not applicable | Completed | Otolith Labs | 51 | 2024-08-27 | 2026-05-19 |
| Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine Amitriptyline, Lifestyle Modification - Vestibular Migraine | Early Phase 1 | Withdrawn | Vanderbilt University Medical Center | 2024-06-19 | 2026-03-31 | |
| SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines Otoband Experimental, Otoband Sham - Vestibular Migraine, Migraine Associated Vertigo | Not applicable | Completed | Otolith Labs | 322 | 2024-03-06 | 2025-01-30 |
| Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent Lifestyle modifications, Vestibular rehabilitation exercise - Vestibular Migraine | Not applicable | Unknown | University of Malaya | 30 | 2023-11-01 | 2023-06-22 |
| Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand Otoband Experimental, Otoband Sham - Vertigo, BPPV | Not applicable | Completed | Otolith Labs | 109 | 2023-02-02 | 2025-03-20 |
| The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients Vestibular Migraine | Unknown | Assiut University | 30 | 2022-12-01 | 2022-08-19 | |
| Local Sensory Nerve Block in the Treatment of Vestibular Migraine Botulinum toxin and bupivacain - Vestibular Migraine | Not applicable | Completed | Pamukkale University | 29 | 2022-07-14 | 2025-06-04 |
| The CAVA Multicentre Dizziness Trial The continuous ambulatory vestibular assessment (CAVA) system - Ménière's Disease, Vestibular Migraine | Not applicable | Completed | Norfolk and Norwich University Hospitals NHS Foundation Trust | 4 | 2022-04-01 | 2026-06-08 |
Showing 20 of 35. Sign in to see all of them.
Vertigo (9) · Migraine Disorders (8) · Dizziness (6) · Meniere Disease (5) · Benign Paroxysmal Positional Vertigo (4) · Vestibular Diseases (4) · Headache Disorders (3) · Vestibular Neuronitis (3) · Fibromyalgia (2) · Headache Disorders, Primary (2) · Headache Disorders, Secondary (2) · Tension-Type Headache (2) · Cluster Headache (1) · Hyperhomocysteinemia (1) · Labyrinthitis (1)
Nervous System Diseases (17) · Ear Diseases (16) · Otorhinolaryngologic Diseases (16) · Labyrinth Diseases (15) · Neurologic Manifestations (15) · Pathological Conditions, Signs and Symptoms (15) · Signs and Symptoms (15) · Vestibular Diseases (11) · Brain Diseases (8) · Central Nervous System Diseases (8) · Sensation Disorders (7) · Headache Disorders, Primary (6) · Endolymphatic Hydrops (5) · Headache Disorders (5) · Cranial Nerve Diseases (4)
rimegepant sulfate (3) · Amitriptyline (2) · Propranolol (2) · Venlafaxine Hydrochloride (2) · Verapamil (2) · erenumab (2) · 4-Aminopyridine (1) · Acupuncture Therapy (1) · Atenolol (1) · Botulinum Toxins (1) · Calcitonin Gene-Related Peptide Receptor Antagonists (1) · Drug Delivery Systems (1) · Flunarizine (1) · Nortriptyline (1) · Sertraline (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (6) · Otolith Labs (4) · Boston Children's Hospital (2) · Ege University (2) · Massachusetts Eye and Ear Infirmary (2) · Norfolk and Norwich University Hospitals NHS Foundation Trust (2) · Vanderbilt University Medical Center (2) · Affiliated Hospital of Jiaxing University (1) · Assiut University (1) · Haseki Training and Research Hospital (1) · I.M. Sechenov First Moscow State Medical University (1) · IRCCS San Raffaele (1) · Istanbul Aydın University (1) · Mayo Clinic (1) · Pamukkale University (1)
United States (13) · China (6) · Turkey (Türkiye) (4) · United Kingdom (2) · Canada (1) · Egypt (1) · Italy (1) · Malaysia (1) · Russia (1)
Didier Depireux, PhD (3) · Jacob R Brodsky, MD (2) · Kaiming Liu, Doctor (2) · Anna Bedenko, PhD student (1) · Brooke Pearce, AuD (1) · Gulce Kirazli, PhD (1) · Jeffrey D Sharon, MD (1) · Jeffrey Staab, MD (1) · John Phillips, Consultant (1) · John Phillips, PhD (1) · Kristen K. Steenerson (1) · Matthew Fitzgerald (1) · Richard A Roberts, PhD (1) · Robert W Baloh, M.D. (1)
PMID 39344988, PMID 11222783, PMID 26224714, PMID 30020261, PMID 31311674, PMID 36946234, PMID 37042545, PMID 37073858, PMID 37210098, PMID 41430107, PMID 20604616, PMID 21884699, PMID 22233684, PMID 23142830, PMID 34325453, PMID 35720061, PMID 37024948, PMID 38819614, PMID 40354049, PMID 42618982
R01DC017425 (1)